{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:28:46Z","timestamp":1764995326414,"version":"3.46.0"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0649","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T22:06:04Z","timestamp":1755554764000},"page":"1299-1307","source":"Crossref","is-referenced-by-count":0,"title":["Primary aldosteronism increases the risk of urinary stones"],"prefix":"10.1507","volume":"72","author":[{"given":"Itsuko","family":"Asayama","sequence":"first","affiliation":[{"name":"Department of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8326-8154","authenticated-orcid":false,"given":"Masakazu","family":"Notsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3859-0125","authenticated-orcid":false,"given":"Masahiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9563-502X","authenticated-orcid":false,"given":"Keizo","family":"Kanasaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Karagiannis A, Skolarikos A, Alexandrescu E, Basic D, Geavlete P, et al. (2017) Epidemiologic study of urolithiasis in seven countries of South-Eastern Europe: S.E.G.U.R. 1 study. Arch Ital Urol Androl 89: 173\u2013177.","DOI":"10.4081\/aiua.2017.3.173"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Liu Y, Chen Y, Liao B, Luo D, Wang K, et al. (2018) Epidemiology of urolithiasis in Asia. Asian J Urol 5: 205\u2013214.","DOI":"10.1016\/j.ajur.2018.08.007"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Chewcharat A, Curhan G (2021) Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis 49: 27\u201339.","DOI":"10.1007\/s00240-020-01210-w"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ferraro PM, Curhan GC, D\u2019Addessi A, Gambaro G (2017) Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J Nephrol 30: 227\u2013233.","DOI":"10.1007\/s40620-016-0283-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Yasui T, Iguchi M, Suzuki S, Okada A, Itoh Y, et al. (2008) Prevalence and epidemiologic characteristics of lower urinary tract stones in Japan. Urology 72: 1001\u20131005.","DOI":"10.1016\/j.urology.2008.06.038"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Qian X, Wan J, Xu J, Liu C, Zhong M, et al. (2022) Epidemiological trends of urolithiasis at the global, regional, and national levels: a population-based study. Int J Clin Pract 2022: 6807203.","DOI":"10.1155\/2022\/6807203"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367: 333\u2013344.","DOI":"10.1016\/S0140-6736(06)68071-9"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8 Choi M, Scholl UI, Yue P, Bj\u00f6rklund P, Zhao B, et al. (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331: 768\u2013772.","DOI":"10.1126\/science.1198785"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Nanba K, Baker JE, Blinder AR, Bick NR, Liu CJ, et al. (2022) Histopathology and genetic causes of primary aldosteronism in young adults. J Clin Endocrinol Metab 107: 2473\u20132482.","DOI":"10.1210\/clinem\/dgac408"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Baudrand R, Guarda FJ, Fardella C, Hundemer G, Brown J, et al. (2017) Continuum of renin-independent aldosteronism in normotension. Hypertension 69: 950\u2013956.","DOI":"10.1161\/HYPERTENSIONAHA.116.08952"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, et al. (2020) The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med 173: 10\u201320.","DOI":"10.7326\/M20-0065"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12 Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, et al. (2018) Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71: 530\u2013537.","DOI":"10.1161\/HYPERTENSIONAHA.117.10263"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Shi S, Lu C, Tian H, Ren Y, Chen T (2020) Primary aldosteronism and bone metabolism: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 11: 574151.","DOI":"10.3389\/fendo.2020.574151"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Notsu M, Yamauchi M, Yamamoto M, Nawata K, Sugimoto T (2017) Primary aldosteronism as a risk factor for vertebral fracture. J Clin Endocrinol Metab 102: 1237\u20131243.","DOI":"10.1210\/jc.2016-3206"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Chang CK, Chang CC, Wu VC, Geng JH, Lee HY (2022) The relationship between renal stones and primary aldosteronism. Front Endocrinol (Lausanne) 13: 828839.","DOI":"10.3389\/fendo.2022.828839"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Chung MC, Lin CL, Wu MJ, Chen CH, Shieh JJ, et al. (2021) Primary aldosteronism is associated with risk of urinary bladder stones in a nationwide cohort study. Sci Rep 11: 7684.","DOI":"10.1038\/s41598-021-86749-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, et al. (2011) Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009. Endocr J 58: 711\u2013721.","DOI":"10.1507\/endocrj.EJ11-0133"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Kang VJ, Lee BC, Huang JZ, Wu VC, Lin YH, et al. (2023) Aldosterone-producing adenoma is associated with urolithiasis in primary aldosteronism. Endocr Connect 12: e230056.","DOI":"10.1530\/EC-23-0056"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Alelign T, Petros B (2018) Kidney stone disease: an update on current concepts. Adv Urol 2018: 3068365.","DOI":"10.1155\/2018\/3068365"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Shey J, Cameron MA, Sakhaee K, Moe OW (2004) Recurrent calcium nephrolithiasis associated with primary aldosteronism. Am J Kidney Dis 44: e7\u2013e12.","DOI":"10.1053\/j.ajkd.2004.03.037"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Abufaraj M, Al Karmi J, Yang L (2022) Prevalence and trends of urolithiasis among adults. Curr Opin Urol 32: 425\u2013432.","DOI":"10.1097\/MOU.0000000000000994"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, et al. (2018) Obesity as a key factor underlying idiopathic hyperaldosteronism. J Clin Endocrinol Metab 103: 4456\u20134464.","DOI":"10.1210\/jc.2018-00866"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Taylor EN, Curhan GC (2006) Body size and 24-hour urine composition. Am J Kidney Dis 48: 905\u2013915.","DOI":"10.1053\/j.ajkd.2006.09.004"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Li Z, Fu C, Sun C, Suo Y, Li K, et al. (2024) Analysis of metabolic syndrome in bilateral upper urinary tract stones: a retrospective study of 3905 cases. Heliyon 10: e31180.","DOI":"10.1016\/j.heliyon.2024.e31180"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/12\/72_EJ24-0649\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:38:12Z","timestamp":1764992292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/12\/72_EJ24-0649\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0649","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"type":"print","value":"0918-8959"},{"type":"electronic","value":"1348-4540"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0649"}}